Economic aspects of the fixed combinations of lipid lowering medicines in group risks patients

• Egile Nagusiak: M. V. Zhuravleva (Egilea), M. Yu. Frolov (Egilea), E. A. Luchinin (Egilea), K. A. Kokushkin (Egilea), E. D. Laryushkina (Egilea), T. R. Kameneva (Egilea), E. V. Kuznetsova (Egilea)
• Formatua: Liburua
• Argitaratua: Izdatelstvo OKI, 2023-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Relevance.  Cardio-vascular diseases (CVD) are the one of the main reasons of mortality and disability. Hypercholesterinemia is a factor of CVD progression, and thus it should be corrected. Combination of statin + ezetemib is an effective option of a medical technology for this purpose. Pharmacoecono...